CVE-2026-24165 is a vulnerability identified in the NVIDIA BioNeMo Framework, a platform used for AI-driven bioinformatics applications. The flaw is categorized under CWE-502, which involves deserialization of untrusted data. Deserialization vulnerabilities occur when software deserializes data from untrusted sources without sufficient validation, potentially allowing attackers to craft malicious input that executes arbitrary code or manipulates program behavior. In this case, the BioNeMo Framework improperly handles deserialization, enabling an attacker who can supply specially crafted input to trigger code execution, denial of service, information disclosure, or data tampering. The vulnerability requires local access (attack vector: local) and user interaction, meaning an attacker must have some level of access to the system and trick a user into processing malicious data. The CVSS v3.1 score of 7.8 reflects high severity, with high impact on confidentiality, integrity, and availability, low attack complexity, no privileges required, and user interaction needed. The vulnerability affects all versions of BioNeMo prior to the commit e5e58c8, which presumably contains the fix. No public exploits or active exploitation have been reported yet. Given the nature of BioNeMo as a specialized framework for bioinformatics and AI, this vulnerability could be leveraged to compromise sensitive research data or disrupt critical computational workflows.

The potential impact of CVE-2026-24165 is significant for organizations using the NVIDIA BioNeMo Framework, especially those in research, healthcare, pharmaceuticals, and AI-driven bioinformatics. Successful exploitation could lead to remote code execution (within the local environment), allowing attackers to run arbitrary commands, potentially gaining further access or persistence. Denial of service could disrupt critical computational tasks or research pipelines, causing operational downtime. Information disclosure could expose sensitive biological or medical data, violating privacy and regulatory compliance. Data tampering could corrupt research results or AI model outputs, undermining scientific integrity and decision-making. Although exploitation requires local access and user interaction, insider threats or compromised user accounts could leverage this vulnerability. The absence of known exploits reduces immediate risk but does not eliminate the threat, especially as attackers may develop exploits once the vulnerability is publicly known. Organizations relying on BioNeMo should consider the risk to confidentiality, integrity, and availability of their data and systems.

To mitigate CVE-2026-24165, organizations should immediately update the NVIDIA BioNeMo Framework to versions including or beyond the commit e5e58c8 that addresses this vulnerability. If patching is not immediately possible, restrict local access to systems running BioNeMo to trusted users only and implement strict access controls and monitoring. Educate users to avoid processing untrusted or unsolicited data inputs within the BioNeMo environment. Employ application whitelisting and endpoint detection to identify suspicious activities related to deserialization or code execution attempts. Network segmentation can limit lateral movement if exploitation occurs. Additionally, review and harden deserialization processes by validating and sanitizing all input data rigorously. Regularly audit and monitor logs for anomalies indicative of exploitation attempts. Finally, maintain up-to-date backups of critical data and workflows to enable recovery in case of denial of service or data tampering.